Immuno Cure is a clinical-stage biotechnology group based in the Hong Kong Science Park, focusing on research and development of innovative DNA medicines and antibody immunotherapies to fight against cancers, inflammatory and infectious diseases based on its patented PD-1-enhanced DNA vaccine, Anti-Δ42PD1 Antibody Immune Blocking technology platforms; and Vaccine Delivery Platform.
